# Phase 10 handoff: Testing and production hardening

## Outcome

Phase 10 completes the outpatient MVP with a passing critical Playwright workflow, live role dashboards, audited patient-account provisioning, paginated audit-log UI/API, stricter environment validation, container health dependencies, and consolidated documentation.

## Tests and quality gates

- Frontend TypeScript and active production ESLint scope pass.
- Frontend production build passes with feature-level lazy chunks.
- Backend TypeScript, 11 unit tests, and Nest production build pass.
- Playwright drives a newly registered synthetic patient through the complete MVP and verifies patient-owned history at the end.
- Docker health, all role logins, reports/CSV, RBAC denials, FEFO allocation, inventory ledger, invoices, payments, and audits are verified.

## Security hardening

- Added minimum 32-character validation for JWT secrets.
- Added audited, admin-only patient portal-account creation.
- Added admin-only paginated audit access with `AUDIT_READ`.
- Retained opaque hashed refresh tokens, HTTP-only cookies, Argon2, Helmet, CORS allowlist, DTO whitelisting, auth rate limits, backend RBAC, and ownership filtering.

## Operational changes

- Backend and PostgreSQL health checks gate Docker startup.
- Role dashboards refresh live metrics every 30 seconds.
- README now documents Docker, credentials, port overrides, tests, structure, and security expectations.

## Known limitations

- Vite reports a non-blocking initial vendor/application chunk warning; all business pages are lazy chunks.
- Dependency audit findings require a separately reviewed dependency-upgrade cycle rather than an unsafe forced update.
- Refunds and external integrations remain explicitly outside MVP scope.
